2011 - CTS-IXA


This page contains exclusive content for the member of the following sections: TTS, CTS, IXA. Log in to view.

Parallel Session 4- Innate Immunity, xenoantigens and antibodies (Xeno Track)

6.136 - Difference in signal transduction between anti-A/B and anti-HLA antibody binding to endothelial cells

Presenter: Kenta, Iwasaki, Nagoya, Japan
Authors: Kenta Iwasaki1, Yuko Miwa1, Masataka Haneda1, Takaaki Kobayashi1

136

Difference in signal transduction between anti-A/B and anti-HLA antibody binding to endothelial cells

Kenta Iwasaki, Yuko Miwa, Masataka Haneda, Takaaki Kobayashi

Department of Applied Immunology, Nagoya University School of Medicine, Nagoya, Aichi, Japan

Background: As even αGal knock-out pigs could not suppress antibody-mediated rejection, much attention has been given to non-Gal antigens including both carbohydrate and protein. Accommodation, no graft injury even in the presence of anti-donor antibody, is a key factor for successful transplantation with anti-donor antibody. However the mechanisms of accommodation are still under debate. Considering that clinical outcome in ABO-incompatible renal transplantation is considerably better than that in HLA-incompatible transplantation, mechanisms of accommodation after antibody binding might also differ between carbohydrate and protein antigens. The purpose of this study is to compare signal transduction between anti-A/B and anti-HLA antibody reaction and to elucidate the mechanisms underlying accommodation.

Method: Blood type A- or B-transferase gene was transfected into human EA.hy926 endothelial cells. After cell sorting, A- or B-expressing cells at high levels were obtained.The expression of CD55/CD59 and HO-1/ferritin H were confirmed by flow-cytometry and quantitative RT-PCR, respectively. Western blots were performed using whole cell lysates with the antibodies against AKT, phosphor-AKT (Ser473), ERK, and phospho-ERK. Cell toxicity was estimated by MTT assay.

Result: Pre-incubation with low levels of anti-HLA or high levels of anti-A/B antibodies for 24 h exhibited resistance against complement-mediated cytotoxicity. Anti-A/B antibody ligation inactivated ERK1/2 pathway and increased complement regulatory proteins such as CD55 and CD59, whereas low titer of anti-HLA ligation activated PI3K/AKT pathway and increased cytoprotective genes such as HO-1 and ferritin H.

Discussion: Complement inhibition by up-regulation of CD55 and CD59 through ERK1/2 inactivation might be a substantial role in accommodation after ABO-incompatible transplantationMechanisms underlying accommodation development seemed to be different between anti-A/B and anti-HLA antibody. Since ERK and PI3K/AKT signaling pathway are widely conserved among several species, analysis of those signal transduction pathways would provide useful information on potential strategy against anti-nonGal antibody.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada